Table 4. Most Common or Relevant Cetuximab-Related Adverse Event Categories by NCI CTC Toxicity Grade (n=58).
| Adverse Event | All grades | Grade 3 to 4 | ||
|---|---|---|---|---|
| Category | No. of patients | % | No. of patients | % |
| Any category | 51 | 88 | 6 | 10 |
| Folliculitis reaction | 31 | 53 | 8 | 0 |
| Asthenia | 13 | 22 | 0 | 0 |
| Dry skin/pruritis | 4 | 7 | 0 | 0 |
| Nausea/vomiting | 3 | 5 | 0 | 0 |
| Nail/hand disorder | 2 | 4 | 0 | 0 |
| Diarrhea | 2 | 4 | 0 | 0 |
| Infusion-related reactions | 2 | 4 | 1 | 2 |
| Pilosity disorder | 2 | 4 | 0 | 0 |
| Pyrexia | 2 | 4 | 0 | 0 |
| Infection | 1 | 2 | 0 | 0 |
| Headache | 1 | 2 | 0 | 0 |
| Interstitial pneumonitis | 1 | 2 | 0 | 0 |
Abbreviations: NCI CTC, National Cancer Institute Common Toxicity Criteria.